Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

Azathioprine can rarely cause hair loss, which improves after stopping the drug.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Compound 4 is a promising treatment for hair loss with low toxicity.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

MK-386 lowers DHT in blood and skin but not in semen.

Ark-e-Kasni improves PCOS symptoms and may be a potential treatment.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.